Showing results (1381-1390 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|June 16, 2011
Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategiesSimon Eckermann, Andrew R WillanPharmacoeconomics|December 23, 2011
Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspectiveAurea Duran, Nishan Sengupta, Alexander Diamantopoulos, et al.Pharmacoeconomics|January 24, 2012
Measuring quality of life in patients with schizophrenia: an updateA George Awad, Lakshmi N P VorugantiPharmacoeconomics|January 31, 2012
Common Drug Review recommendations: an evidence base for expectations?Angela Rocchi, Elizabeth Miller, Robert B Hopkins, et al.Pharmacoeconomics|January 31, 2012
Contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001-7Frank R LichtenbergPharmacoeconomics|January 31, 2012
Population- versus cohort-based modelling approachesOlivier Ethgen, Baudouin StandaertPharmacoeconomics|January 25, 2012
Anti-inflammatory medication adherence, healthcare utilization and expenditures among Medicaid and children's health insurance program enrollees with asthmaJill Boylston Herndon, Soeren Mattke, Alison Evans Cuellar, et al.Pharmacoeconomics|October 13, 2011
Sample size determination for cost-effectiveness trialsAndrew R WillanPharmacoeconomics|November 16, 2010
Availability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema and chronic myeloid leukaemiaCarl Rudolf Blankart, Tom Stargardt, Jonas SchreyöggPharmacoeconomics|December 15, 2010
Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteriaJonathan Karnon, Tazio VanniPageof 336